Surgical Treatment of Atrial Fibrillation

Navaratnarajah, Manoraj; Luthra, Suvitesh; Ohri, Sunil K.

doi:10.5772/intechopen.91225

Cited by 2 publications

(2 citation statements)

References 99 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most commonly reported complications of the procedure are pulmonary vein stenosis, tamponade, pacemaker implantation, stroke, respiratory infections, renal failure, bleeding, and death. The literature describes mortality rates of less than 0.5% [25]. Surgical complications are relatively rare.…”

Section: Discussionmentioning

confidence: 99%

Long-Term Results of the Mini Maze Standalone Bi-Atrial Surgical Ablation: A 10-Year Follow-Up

Radauskaite,

Rackauskas,

Danilenko

et al. 2024

JCM

View full text Add to dashboard Cite

Background: One way to treat atrial fibrillation is through surgical ablation. However, the literature only provides information on patient follow-up results for up to 5 years. Methods: In order to assess long-term monitoring data over ten years, this retrospective study included 58 patients with paroxysmal or persistent atrial fibrillation who underwent Mini Maze surgical ablation at Santaros Clinics between 1 February 2009 and 1 June 2014. The follow-up time after surgery was 144 ± 48 months. We evaluated the absence of atrial fibrillation, echocardiographic and clinical parameters, and EHRA score. Results: Sinus rhythm remained in 69.4%, 75.5%, 55.6%, and 44.1% of patients with paroxysmal AF, and 68,2%, 59.1%, 50%, and 41.9% of patients with persistent AF (p = 0.681). In the post-operative period, one patient (1.7%) had a transient ischemic attack, and another patient (1.7%) had a thoracotomy for post-operative bleeding. A total of 20% of patients were diagnosed with a post-operative respiratory tract infection. EHRA scores showed that patients’ quality of life improved after they underwent Mini Maze surgical ablation. Conclusions: Despite AF recurrences after surgery, quality of life remains better than before surgery, showing that Mini Maze surgery is an effective and safe second-line treatment method for atrial fibrillation.

show abstract

Section: Discussionmentioning

confidence: 99%

Long-Term Results of the Mini Maze Standalone Bi-Atrial Surgical Ablation: A 10-Year Follow-Up

Radauskaite,

Rackauskas,

Danilenko

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

“…The novel guidelines of surgical treatment of AF published by the Society of Thoracic Surgeons in 2017 recommends rhythm monitoring 3, 6, 9, 12, and 24 months after the procedures, preferably with 24-hour Holter monitoring (3). The recurrence is defined as any atrial arrhythmia longer than 30 seconds (50). Although in guidelines of the European Society of Cardiology there is no clear information on how patients should be monitored, especially after invasive treatment, it is recommended to perform longer period monitoring, such as a 7-day Holter or implantable loop recorders rather than sole 24-hour Holter.…”

Section: Rhythm Monitoringmentioning

confidence: 99%

Insights from advancements and pathbreaking research on the minimally invasive treatment of atrial fibrillation

Witkowska

Suwalski

2021

J Thorac Dis

View full text Add to dashboard Cite

Atrial fibrillation (AF) remains the most common cardiac arrhythmia with increasing prevalence in developed and aging countries. Pharmacological antiarrhythmic therapy has low effectiveness and is limited by its toxicity. Developed in 1987 by James Cox surgical ablation of AF called MAZE procedure was very effective, but due to its invasiveness and complexity was not widely adopted. Landmark research done by Haissaguerre in 1998 initiated a new approach for treatment namely percutaneous catheter ablation, which remains a class I/A indication in symptomatic paroxysmal AF refractory to optimal medical therapy. However, its efficacy in patients with persistent atrial fibrillation (PSAF) is far from satisfactory. Recent advancements in devices and techniques of minimally invasive surgical ablation show very good results in the treatment of PSAF. Current guidelines equate surgical with catheter ablation within the scope of efficacy indicating that both may be considered as an effective and safe treatment option for patients with persistent forms of arrhythmia. The higher efficacy of surgical ablation was confirmed at a 7-year follow-up of FAST trial with recurrence rate as high as 87% in catheter arm compared with 56% in thoracoscopic ablation arm. A new concept of the invasive treatment of AF consisting of combined surgical (epicardial) and electrophysiological (endocardial) was introduced in 2009. Recently experts' opinions and published data suggest that the proper hybrid treatment consisting of a planned combination of surgical and catheter ablation may give even better results. One of the most invaluable benefits of surgical ablations is the possibility of concomitant occlusion of the left atrial appendage. Recently good results have been reported for the novel epicardial clip for closing the left atrial appendage, which is placed in the deployment loop on a disposable holder.

show abstract

Surgical Treatment of Atrial Fibrillation

Cited by 2 publications

References 99 publications

Long-Term Results of the Mini Maze Standalone Bi-Atrial Surgical Ablation: A 10-Year Follow-Up

Long-Term Results of the Mini Maze Standalone Bi-Atrial Surgical Ablation: A 10-Year Follow-Up

Insights from advancements and pathbreaking research on the minimally invasive treatment of atrial fibrillation

Contact Info

Product

Resources

About